Appetite suppression from the GLP-1 and GIP components appears well-maintained with microdosing, particularly at twice-weekly frequency
Most notably, the top causes of human death, heart disease, diabetes, kidney disease, liver inflammation (fatty liver) but also improving joint issues that can be caused by excess weight, aging and inactivity including back, hip and knee pain and surgeries
A GLP-1 pill offers a chance to push that progress even further if we can figure out how to expand access and how to better support patients so they can lose weight in a healthy way
The most effective sequence appears to be fibre and vegetables first, then protein and fats, with carbohydrates last, says Jean-Marc
Rather than assuming all patients experience side effects equally, PlexusDx helps bridge the gap between genetic predisposition and clinical practice, enabling discussions about tailored dosing, formulation choice, and escalation speed based on your unique biology